Gilead Sciences Aktie
152,62
EUR
+0,74
EUR
+0,49
%
168,40
USD
+0,42
USD
+0,25
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
Gilead Sciences Aktie Analyse
| 07.11.12 | Gilead Sciences outperform | Sanford C. Bernstein and Co., Inc. | |
| 25.10.12 | Gilead Sciences hold | Jefferies & Company Inc. | |
| 25.10.12 | Gilead Sciences buy | Needham & Company, LLC | |
| 15.10.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 03.10.12 | Gilead Sciences buy | UBS AG | |
| 02.10.12 | Gilead Sciences outperform | Sanford C. Bernstein and Co., Inc. | |
| 27.09.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 30.08.12 | Gilead Sciences buy | UBS AG | |
|
Werbung
|
|||
| 29.08.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 29.08.12 | Gilead Sciences hold | Jefferies & Company Inc. | |
| 28.08.12 | Gilead Sciences buy | Stifel, Nicolaus & Co., Inc. | |
| 27.08.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 20.08.12 | Gilead Sciences overweight | JP Morgan Chase & Co. | |
| 17.08.12 | Gilead Sciences buy | Citigroup Corp. | |
| 16.08.12 | Gilead Sciences buy | Deutsche Bank Securities | |
| 24.07.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 16.07.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 12.07.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 29.06.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 22.06.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 19.06.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 25.05.12 | Gilead Sciences kaufen | Der Aktionär | |
| 02.05.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 30.04.12 | Gilead Sciences buy | Citigroup Corp. | |
| 30.04.12 | Gilead Sciences outperform | Needham & Company, LLC | |
| 24.04.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 20.03.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 16.03.12 | Gilead Sciences buy | Stifel, Nicolaus & Co., Inc. | |
| 24.02.12 | Gilead Sciences overweight | JP Morgan Chase & Co. | |
| 23.02.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 16.02.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 06.02.12 | Gilead Sciences buy | UBS AG | |
| 06.02.12 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 06.02.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 06.02.12 | Gilead Sciences buy | Deutsche Bank Securities | |
| 03.02.12 | Gilead Sciences buy | Needham & Company, LLC | |
| 25.01.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 20.01.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 09.01.12 | Gilead Sciences buy | Needham & Company, LLC | |
| 12.12.11 | Gilead Sciences neutral | Credit Suisse Group | |
| 01.12.11 | Gilead Sciences overweight | Piper Jaffray & Co. | |
| 30.11.11 | Gilead Sciences buy | Goldman Sachs Group Inc. | |
| 30.11.11 | Gilead Sciences buy | Citigroup Corp. | |
| 29.11.11 | Gilead Sciences buy | Deutsche Bank Securities | |
| 29.11.11 | Gilead Sciences neutral | Credit Suisse Group | |
| 28.11.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 23.11.11 | Gilead Sciences buy | Citigroup Corp. | |
| 22.11.11 | Gilead Sciences buy | UBS AG | |
| 16.11.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 11.10.11 | Gilead Sciences neutral | Citigroup Corp. | |
Werbung
Werbung